ÂÜÀòÂÒÂ×

Fabien Granier has a diverse work experience in various roles and industries. Fabien co-founded BIODOL Therapeutics in 2014 and currently serves as the CEO. The company focuses on developing compounds for the treatment of chronic neuropathic pain. Fabien has also co-founded Colcom in 2006, a company that produces and markets nanomolecules internationally. Prior to that, they worked as a Projects Manager at Languedoc Roussillon Incubation from 2002 to 2006, where they provided coaching and support to startup creators. Fabien was also involved in a project called TIC from 2001 to 2002, which aimed to create a LinkedIn-like platform. Although this project did not result in an actual enterprise, Fabien gained valuable experience in human relationships, management, administration, and business.

Fabien Granier pursued their education from 1997 to 2000 at the University of Montpellier, where they successfully completed their Doctor of Philosophy (PhD) in Quantum Chemistry.